Sojitz Eyes Growth in Australia and Uzbekistan with New Investment Strategy Market Talks Roundup Insights on Experian SoFi Technologies and Financial Services Sector Quantum Computing Stocks Rally on US Governments 2 Billion Funding Plan Bitcoin ETFs See 226 Billion in Outflows Over Two Weeks Credit Suisse Economist Predicts Repo Rate Could Hit Decade Low Market Rally Possible from December Treasury Yield Surge Challenges RiskFree Asset Assumptions as Geopolitical Tensions and Inflation Reshape Fed Policy Outlook NOV Q1 2026 Earnings EPS Misses Estimates Sharply as Revenue Details Remain Unreported SCNX Q1 2026 Earnings Strong EPS Beat Driven by Cost Management Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines Mistras Group Inc MG Q1 2026 Earnings EPS Surges Past Estimates with 55 Surprise VIPS Q4 2025 Earnings EPS Surprise Lifts Sentiment Amid Modest Stock Pullback PLBC Q1 2026 Earnings EPS Beat of 712 Offsets Modest Share Price Decline Stratus Properties STRS Edges Lower as Stock Tests Key Support Levels GPJA Edges Higher Georgia Power Subordinated Notes Test Resistance at 2225 Hamilton Insurance Group HG Slips 1 as Shares Hold Above Key Support NewHold Investment Corp III NHIC Holds Steady at 1057 as SPAC Market Waits National Storage Affiliates Trust NSA Rises Slightly as Support Holds Key Levels in Focus Navigating Rupee Stability and Growth Indias Forex and Investment Strategy DKS Q1 2026 Earnings EPS Surges 19 Above Estimates Yet Stock Declines Hovnanian Enterprises HOV Slips 886 as Housing Headwinds Intensify STRRP Q1 2026 Earnings Preferred Stock Reports Sharp EPS Miss Yet Shares Gain Skye Bioscience Inc SKYE Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Surges on Pipeline Progress ABG Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement FSP Q4 2025 Earnings Earnings Surge Past Estimates with Positive EPS SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Navigates Pipeline Progress Outset Medical Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Immunovant IMVT Q1 2026 Earnings EPS Miss Driven by Higher RD Investment Stock Holds Steady